The U.S. Supreme Court is allowing investors to file a class action lawsuit against Matrixx Initiatives, Inc. (MTXX), the makers of Zicam Cold Remedy, for failing disclose initial reports that the cold remedy can produce loss of smell in some users.
The high court ruled unanimously in favor of Matrixx investors who wish to sue the company in a securities fraud class action lawsuit. Matrixx settled several consumer Zicam class action lawsuits last summer.
In 2009, U.S. regulators told Matrixx to stop selling two intra-nasal forms of Zicam after receiving more than 150 complaints from people who said they lost their sense of smell from using the product. Matrixx pulled those versions of Zicam but claimed the product was safe. Investors, however, discovered in 2000 that researchers had in fact reported the risk of the problem, known as anosmia, from using the product.
“This is not a case about a handful of anecdotal reports, as Matrixx suggests,” wrote Justice Sonia Sotomayor. “Matrixx received information that plausibly indicated a reliable causal link between Zicam and anosmia. That information included reports from three medical professionals and researchers about more than 10 patients who had lost their sense of smell after using Zicam.”
Updated March 24th, 2011
All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions
Top Class Actions Legal Statement


3 thoughts onMatrixx Investors Can Pursue Zicam Class Action Lawsuit
Add me
HAVE LOST OF SMELL WHICH LEADS TO LOSS OF TASTE… WHERE DO WE TURN IN NOV 2109?
I just learned that there is a connection between Zicam use and loss of smell. I have been aware that I don’t smell things other people say “stink.” I don’t smell perfume when others say “I like your scent.” I used Zicam nasal swabs about 2.5 – 3 years ago. What should I do now?